Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor. 2022

Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
Cellular Signaling laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of MOE, College of Life Science and Technology, Huazhong University of Science and Technology, 430074, Wuhan, Hubei, China.

G protein-coupled receptors (GPCRs) are important drug targets that mediate various signaling pathways by activating G proteins and engaging β-arrestin proteins. Despite its importance for the development of therapeutics with fewer side effects, the underlying mechanism that controls the balance between these signaling modes of GPCRs remains largely unclear. Here, we show that assembly into dimers and oligomers can largely influence the signaling mode of the platelet-activating factor receptor (PAFR). Single-particle analysis results show that PAFR can form oligomers at low densities through two possible dimer interfaces. Stabilization of PAFR oligomers through cross-linking increases G protein activity, and decreases β-arrestin recruitment and agonist-induced internalization significantly. Reciprocally, β-arrestin prevents PAFR oligomerization. Our results highlight a mechanism involved in the control of receptor signaling, and thereby provide important insights into the relationship between GPCR oligomerization and downstream signaling.

UI MeSH Term Description Entries
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D000071557 beta-Arrestins Non-visual system arrestins that negatively regulate G-PROTEIN-COUPLED RECEPTORS (GPCRs) and may also function independently of GPCR signaling. They bind and recruit many different signaling factors, including MITOGEN-ACTIVATED PROTEIN KINASES; SRC-FAMILY-KINASES; and FILAMIN to GPCRs and may recognize different phosphorylation states of the receptors to determine the specificity of the cellular response to signaling. beta-Arrestin,beta Arrestin,beta Arrestins
D000071559 beta-Arrestin 1 A beta-arrestin that functions in the down-regulation of signaling by G-PROTEIN-COUPLED RECEPTORS. It is also a major regulator of INSULIN signaling via the ERK 1-2 PATHWAY, and many other signaling processes, especially in NEURONS and LEUKOCYTES. ARRB1 Protein,Arrestin, beta 1,Arrestin-2,beta-Arrestin 1A,beta-Arrestin 1B,Arrestin 2,beta 1 Arrestin,beta Arrestin 1,beta Arrestin 1A,beta Arrestin 1B
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory

Related Publications

Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
March 2021, Canadian journal of physiology and pharmacology,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
September 2002, Journal of neurochemistry,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
January 2004, Circulation research,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
March 2016, Journal of cardiovascular pharmacology,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
May 2018, Circulation,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
January 2022, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
October 2010, Journal of receptor and signal transduction research,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
February 2020, Science (New York, N.Y.),
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
February 2020, Cell communication and signaling : CCS,
Junke Liu, and Hengmin Tang, and Chanjuan Xu, and Shengnan Zhou, and Xunying Zhu, and Yuanyuan Li, and Laurent Prézeau, and Tao Xu, and Jean-Philippe Pin, and Philippe Rondard, and Wei Ji, and Jianfeng Liu
December 2003, Frontiers in neuroendocrinology,
Copied contents to your clipboard!